The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial
Nasser Ebrahimi Daryani
1
, *
,
Babak Haghpanah
2
,
Ali Reza Sayyah
2
,
Ali Asad Hashtroudi
2
,
Mohammad Bashashati
2
,
Parisa Poursamimi
2
and
Mehri Nikbin
2
1 Tehran University of Medical Sciences, Imam Khomeini Hospital & Study Group of Interferon in Iran (SG.IFN.IR), nebrahim@sina.tums.ac.ir, Tehran, IR.Iran
2 Tehran University of Medical Sciences, Imam Khomeini Hospital, Tehran, IR.Iran
To Cite:
Daryani
N, Haghpanah
B, Sayyah
A, Hashtroudi
A, Bashashati
M, et al. The Efficacy and Side Effects of Therapy with Peginterferon Alpha-2 a (PEGASYS) Combined with Ribavirin in Chronic Hepatitis C Patients: an open label Clinical Trial,
Hepat Mon.
Online ahead of Print
; 4(7):71-74.
Readers' Comments